Drug intelligence / Profile preview

lobelia chinensis

Development stage
Preclinical
Administration
Oral
01

Overview

**Lobelia chinensis** is a creeping perennial plant belonging to the Campanulaceae family, native to China and East Asia. It is regarded as one of the 50 fundamental herbs in Traditional Chinese Medicine (TCM) and used for conditions such as fever, acute inflammation, lung cancer, edema, snakebites, acute heart failure, and other ailments. Its mechanism of action is primarily anti-inflammatory and anti-oxidant, most notably through suppression of inflammatory cytokines (TNF-α, IL-1β, IL-6) and inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) via NF-κB pathway modulation[1][5][9]. Unlike Lobelia inflata, it does **not** contain lobeline[5]. Chemical constituents include piperidine alkaloids (excluding lobeline), coumarins, flavonoids, polyacetylenes, and alkaloid-lignan hybrids[3][5]. It exhibits diuretic, antispasmodic, and circulatory balancing properties and has demonstrated biological activities related to cancer, inflammation, bacterial and viral infections, and liver diseases[1][5][9]. Mild toxicity has been reported, with adverse reactions including nausea, vomiting, heartburn, anxiety, and, in larger doses, potentially severe effects[3][4].

Other names
Chinese lobeliaBan Bian LianLcL
02

Targets

IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CDK1 (Cyclin-dependent kinase 1)NOS2 (Nitric Oxide Synthase 2)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on lobelia chinensis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lobelia chinensis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call